Insitu Biologics
About:
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and proprietary treatments.
Website: http://insitubiologics.com/
Twitter/X: InSituBiologics
Top Investors: Manhattan Street Fund
Description:
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and proprietary treatments using its Matrix BioHydrogel. The company's platform develops and manufactures implantable time release products composed of its proprietary tunable and bio-polymeric hydro-gel by using hard particulates in soft matrix, enabling patients to get relieve from peri-operative regional pain by a long-lasting and long-acting non-opiate painkiller.
$6.97M
$1M to $10M
Minnesota City, Minnesota, United States
2014-01-01
katie(AT)insitubiologics.com
Bill Taylor, James Segermark
11-50
2021-02-24
Private
© 2025 bioDAO.ai